Literature DB >> 18520722

Multiple actions of high-density lipoprotein.

Matilda Florentin1, Evangelos N Liberopoulos, Anthony S Wierzbicki, Dimitri P Mikhailidis.   

Abstract

PURPOSE OF REVIEW: The most accepted property of high-density lipoprotein is reverse cholesterol transport. However, other beneficial actions may contribute to the antiatherogenic role of high-density lipoprotein. This review addresses the action of high-density lipoprotein beyond reverse cholesterol transport. RECENT
FINDINGS: High-density lipoprotein cholesterol levels are inversely associated with coronary heart disease and other forms of vascular disease. Apart from transferring excess cholesterol to the liver, high-density lipoprotein exhibits favorable effects on oxidation, inflammation, thrombosis and endothelial function. Some of these actions are at least in part attributed to high-density lipoprotein-associated enzymes, such as paraoxonase and platelet-activating factor acetylhydrolase. However, high-density lipoprotein can become dysfunctional and proatherogenic under certain circumstances.
SUMMARY: Current data suggest that high-density lipoprotein possesses various properties beyond reverse cholesterol transport. However, many issues on the exact role of high-density lipoprotein remain unknown. Future research is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520722     DOI: 10.1097/HCO.0b013e3283043806

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  61 in total

1.  oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.

Authors:  Jingyi Ren; Wenying Jin; Hong Chen
Journal:  Mol Cell Biochem       Date:  2010-05-11       Impact factor: 3.396

2.  The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

Authors:  Torjus Skajaa; David P Cormode; Peter A Jarzyna; Amanda Delshad; Courtney Blachford; Alessandra Barazza; Edward A Fisher; Ronald E Gordon; Zahi A Fayad; Willem J M Mulder
Journal:  Biomaterials       Date:  2011-01       Impact factor: 12.479

Review 3.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

Review 4.  Dysfunctional high-density lipoprotein and atherosclerosis.

Authors:  Shawn Ragbir; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2010-09       Impact factor: 5.113

5.  Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway.

Authors:  Zhen-Yu Peng; Shui-Ping Zhao; Bai-Mei He; Dao-Quan Peng; Min Hu
Journal:  Mol Cell Biochem       Date:  2011-01-25       Impact factor: 3.396

Review 6.  Cardiovascular implications from untreated human immunodeficiency virus infection.

Authors:  Jason V Baker; Jens D Lundgren
Journal:  Eur Heart J       Date:  2011-01-12       Impact factor: 29.983

7.  Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

Authors:  K G Lagos; T D Filippatos; V Tsimihodimos; I F Gazi; C Rizos; A D Tselepis; D P Mikhailidis; Moses S Elisaf
Journal:  Lipids       Date:  2008-10-28       Impact factor: 1.880

8.  High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

Authors:  Jason Baker; Woubeshet Ayenew; Harrison Quick; Katherine Huppler Hullsiek; Russell Tracy; Keith Henry; Daniel Duprez; James D Neaton
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  15-lipoxygenase-mediated modification of HDL3 impairs eNOS activation in human endothelial cells.

Authors:  Lucia Cutuli; Angela Pirillo; Patrizia Uboldi; Hartmut Kuehn; Alberico L Catapano
Journal:  Lipids       Date:  2014-02-26       Impact factor: 1.880

10.  Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.

Authors:  Björn Andersson; Gunnel Hellgren; Andreas F M Nierop; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2009-11-02       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.